𝔖 Bobbio Scriptorium
✦   LIBER   ✦

40 DEGARELIX VERSUS LEUPROLIDE IN PATIENTS WITH PROSTATE CANCER: EFFECT IN METASTATIC PATIENTS AS ASSESSED BY SERUM ALKALINE PHOSPHATASE

✍ Scribed by F.H. Schröder; L. Boccon-Gibod; B. Tombal; K. Miller; J.K. Jensen; T.K. Olesen; B.-E. Persson

Book ID
119619383
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
510 KB
Volume
8
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changes in alkaline phosphatase levels i
Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study
✍ Fritz H. Schröder; Bertrand Tombal; Kurt Miller; Laurent Boccon-Gibod; Neal D. S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

Study Type – Therapy (RCT)
Level of Evidence 1b ## OBJECTIVE To compare the activity of degarelix, a new gonadotrophin‐releasing hormone (GnRH) blocker, with leuprolide depot 7.5 mg in the control of total serum alkaline phosphatase (S‐ALP) levels in patients with prostate cancer. ## PATIENTS AND